This statistic displays a projection of the top 10 orphan R & D products ( phase III/filed ) by net present value as of 2020 . Ide-Cel had a net present value of 6.2 billion U.S. dollars . Orphan drugs are used to target rare diseases or disorders , which in the United States is defined as less than 200,000 patients . The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983 .
